Invention Grant
- Patent Title: PGDH inhibitors and methods of making and using
-
Application No.: US17725220Application Date: 2022-04-20
-
Publication No.: US11891389B2Publication Date: 2024-02-06
- Inventor: Roopa Rai , Robert Booth , Michael J. Green
- Applicant: Myoforte Therapeutics, Inc.
- Applicant Address: US CA Menlo Park
- Assignee: Myoforte Therapeutics, Inc.
- Current Assignee: Myoforte Therapeutics, Inc.
- Current Assignee Address: US CA Menlo Park
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00
Abstract:
Disclosed herein are compounds that can inhibit 15-hydroxyprostaglandin dehydrogenase. Such compounds may be administered to subjects that may benefit from modulation of prostaglandin levels.
Public/Granted literature
- US20220267325A1 PGDH INHIBITORS AND METHODS OF MAKING AND USING Public/Granted day:2022-08-25
Information query
